| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |